Med BioGene Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced net loss was USD 63,475 compared to USD 54,617 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.